Changeflow GovPing Pharma & Drug Safety Split PYP Complementation System for Detecting ...
Routine Notice Added Final

Split PYP Complementation System for Detecting Protein Interactions

Favicon for changeflow.com USPTO Patent Grants - Peptides (C07K)
Published
Detected
Email

Summary

USPTO granted patent US12590127B2 to PARIS SCIENCES ET LETTRES for a split photoactive yellow protein (PYP) complementation system for detecting protein interactions. The patent covers two PYP fragments with at least 70% sequence identity to SEQ ID NO:23 and SEQ ID NO:34, used with fluorogenic HBR analogs for protein interaction detection. The grant includes 19 allowed claims.

Published by USPTO on changeflow.com . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

What changed

USPTO issued Patent No. US12590127B2 to inventors Arnaud Gautier and Alison Tebo, assigned to PARIS SCIENCES ET LETTRES, covering a split photoactive yellow protein (PYP) complementation system. The invention comprises two PYP fragments—one with at least 70% identity to SEQ ID NO:23 (including truncated fragments of at least 89 consecutive C-terminal amino acids) and another with at least 70% identity to SEQ ID NO:34 (including truncated fragments of at least 8 consecutive N-terminal amino acids)—used with hydroxybenzylidene rhodanine analogs for detecting protein-protein interactions.

This patent grant establishes exclusive rights for the assignee in the United States. Entities conducting protein interaction research or developing protein detection assays should review the patent claims to assess potential licensing needs. The patent is classified under CPC codes C07K 14/195, C07K 7/06, G01N 33/582, and related categories, indicating broad applicability in biotechnology and pharmaceutical research contexts.

Archived snapshot

Mar 31, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

← USPTO Patent Grants

Split photoactive yellow protein complementation system and uses thereof

Grant US12590127B2 Kind: B2 Mar 31, 2026

Assignee

PARIS SCIENCES ET LETTRES

Inventors

Arnaud Gautier, Alison Tebo

Abstract

A complementation system including two fragments of photoactive yellow protein (PYP), or truncated fragments thereof, and its use with a fluorogenic hydroxybenzylidene rhodanine (HBR) analog for detecting interactions between biological molecules of interest, in particular between proteins of interest. Especially, a complementation system including a first PYP fragment having an amino acid sequence having at least about 70% identity with the amino acid sequence of SEQ ID NO: 23, or a truncated fragment thereof including at least 89 consecutive amino acids from the C-terminal end of the amino acid sequence; and a second PYP fragment having an amino acid sequence having at least about 70% identity with the amino acid sequence of SEQ ID NO: 34, or a truncated fragment thereof including at least 8 consecutive amino acids of the amino acid sequence, preferably 8 consecutive amino acids from the N-terminal end of the amino acid sequence.

CPC Classifications

C07K 14/195 C07K 7/06 C07K 19/00 C07K 2319/60 C07D 277/36 C07D 277/34 G01N 33/582 G01N 33/6845

Filing Date

2020-04-03

Application No.

17600329

Claims

19

View original document →

Get daily alerts for USPTO Patent Grants - Peptides (C07K)

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from USPTO.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
USPTO
Published
March 31st, 2026
Instrument
Notice
Legal weight
Binding
Stage
Final
Change scope
Minor
Document ID
US12590127B2

Who this affects

Applies to
Pharmaceutical companies Investors Manufacturers
Industry sector
3254.1 Biotechnology
Activity scope
Patent Grant Biotechnology IP
Geographic scope
United States US

Taxonomy

Primary area
Intellectual Property
Operational domain
Legal
Topics
Biotechnology Pharmaceuticals

Get alerts for this source

We'll email you when USPTO Patent Grants - Peptides (C07K) publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!